Search Results

There are 10058 results for: content related to: Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study

  1. Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer’s disease

    International Journal of Clinical Practice

    Volume 65, Issue 4, April 2011, Pages: 465–471, G. T. Grossberg, J. T. Olin, M. Somogyi and X. Meng

    Article first published online : 11 FEB 2011, DOI: 10.1111/j.1742-1241.2011.02641.x

  2. Similar Rivastigmine Pharmacokinetics and Pharmacodynamics in Japanese and White Healthy Participants Following the Application of Novel Rivastigmine Patch

    The Journal of Clinical Pharmacology

    Volume 49, Issue 4, April 2009, Pages: 430–443, Dr Gilbert Lefèvre, Ms Monika Büche, Dr Greg Sedek, Mr Steve Maton, Dr Albert Enz, Dr Ulrike Lorch, Dr Cyriaque Sagan and Dr Silke Appel-Dingemanse

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008330161

  3. You have free access to this content
    A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule

    International Journal of Geriatric Psychiatry

    Volume 22, Issue 5, May 2007, Pages: 456–467, Bengt Winblad, Jeffrey Cummings, Niels Andreasen, George Grossberg, Marco Onofrj, Carl Sadowsky, Stefanie Zechner, Jennifer Nagel and Roger Lane

    Article first published online : 22 MAR 2007, DOI: 10.1002/gps.1788

  4. Rivastigmine for Alzheimer's disease

    Intervention Review

    The Cochrane Library

    Jacqueline S Birks and John Grimley Evans

    Published Online : 10 APR 2015, DOI: 10.1002/14651858.CD001191.pub3

  5. You have free access to this content
    Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 4, August 2010, Pages: 246–253, Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez-Lage, Andreas Monsch, Magda Tsolaki and Teus Van Laar

    Article first published online : 29 MAR 2010, DOI: 10.1111/j.1755-5949.2010.00141.x

  6. Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease

    International Journal of Clinical Practice

    G. Alva, J. L. Cummings, J. E. Galvin, X. Meng and D. M. Velting

    Article first published online : 16 FEB 2015, DOI: 10.1111/ijcp.12621

  7. Rivastigmine, a New-Generation Cholinesterase Inhibitor for the Treatment of Alzheimer's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 20, Issue 1, January 2000, Pages: 1–12, Michael W. Jann

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.20.1.1.34664

  8. Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 2, February 2008, Pages: 246–252, Dr Gilbert Lefèvre, Mrs Françoise Pommier, Dr Greg Sędek, Dr Mark Allison, Dr Hsun-Lun Aaron Huang, Mrs Beate Kiese, Dr Yu-Yun Ho and Dr Silke Appel-Dingemanse

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007312154

  9. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 5, May 2007, Pages: 545–551, S. V. Frankfort, B. A. Appels, A. de Boer, L. R. Tulner, J. P. C. M. van Campen, C. H. W. Koks, J. H. Beijnen and B. A. Schmand

    Article first published online : 16 NOV 2006, DOI: 10.1002/pds.1345

  10. Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application

    The Journal of Clinical Pharmacology

    Volume 47, Issue 4, April 2007, Pages: 471–478, Dr Gilbert Lefèvre, Dr Greg Sędek, Dr Hsun-Lun Aaron Huang, Dr Marc Saltzman, Dr Mitchell Rosenberg, Dr Beate Kiese and Dr Peter Fordham

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006297748

  11. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

    International Journal of Clinical Practice

    Volume 60, Issue 1, January 2006, Pages: 110–118, T. Dantoine, 1 S. Auriacombe, 2 M. Sarazin, 3 H. Becker, 4 J-J Pere and 5 I. Bourdeix 5

    Article first published online : 20 DEC 2005, DOI: 10.1111/j.1368-5031.2005.00769.x

  12. Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 3, March 2004, Pages: 243–249, A. Burns, R. Spiegel and P. Quarg

    Article first published online : 13 FEB 2004, DOI: 10.1002/gps.1058

  13. Absorption of Rivastigmine from Different Regions of the Gastrointestinal Tract in Humans

    The Journal of Clinical Pharmacology

    Volume 44, Issue 6, June 2004, Pages: 599–604, Dr. Lucy Lee, Dr. Mohammad Hossain, Dr. Yanfeng Wang and Dr. Greg Sedek

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270004265645

  14. You have free access to this content
    Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 6, December 2010, Pages: 330–336, Frederick A. Schmitt, Martin R. Farlow, Xiangyi Meng, Sibel Tekin and Jason T. Olin

    Article first published online : 15 OCT 2010, DOI: 10.1111/j.1755-5949.2010.00182.x

  15. Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand

    Psychogeriatrics

    Volume 13, Issue 1, March 2013, Pages: 1–8, Kongkiat KULKANTRAKORN, Panas TANYAKITPISAL, Somchai TOWANABUT, Charungthai DEJTHEVAPORN, Poonsri RANGSEEKAJEE, Sunsanee PONGPAKDEE, Somsak LAPTIKULTHAM, Kritsada RODPRASERT, Suwanna SETTHAWATCHARAWANICH and Bandit THINKHAMROP

    Article first published online : 17 FEB 2012, DOI: 10.1111/j.1479-8301.2012.00403.x

  16. You have free access to this content
    Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions

    Psychogeriatrics

    Volume 12, Issue 3, September 2012, Pages: 165–171, Peter PREGELJ

    Article first published online : 20 SEP 2012, DOI: 10.1111/j.1479-8301.2011.00400.x

  17. You have free access to this content
    Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies

    Drug Development Research

    Volume 64, Issue 1, January 2005, Pages: 71–81, Ramesh C. Gupta and A. Dekundy

    Article first published online : 19 APR 2005, DOI: 10.1002/ddr.10422

  18. Donepezil- or rivastigmine-induced acetylcholinesterase inactivation is not modulated by neramexane in rat brain

    Drug Development Research

    Volume 68, Issue 5, August 2007, Pages: 253–260, Ramesh C. Gupta and Andrzej Dekundy

    Article first published online : 13 NOV 2007, DOI: 10.1002/ddr.20186

  19. Treatment of Alzheimer's Disease (With or Without Cerebrovascular Disease)

    Evidence-based Dementia Practice

    Lon S. Schneider, Nawab Qizilbash, Mary Sano, Fadi Massoud, Jeffrey Kaye, Jason T. Olin, Knut Laake, Anne Rita Øksengaard, Barry S. Oken, Kristine Yaffe, Kentaro Hashimoto, Jesus López-Arrieta, John C. S. Breitner, Leon Flicker, Kenneth Rockwood, Josẽ Luísrodríquez-Martin, Pages: 467–588, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470752340.ch34

  20. Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

    CNS Neuroscience & Therapeutics

    Martin R. Farlow, Carl H. Sadowsky, Drew M. Velting, Xiangyi Meng and M. Zahur Islam

    Article first published online : 10 FEB 2015, DOI: 10.1111/cns.12385